Personalis Stock

Personalis Current Assets

The Current Assets of Personalis (PSNL) as of Aug 5, 2026 is 251.75 M USD. In the previous year, Current Assets was 203.02 M USD — a change of 24.00% (higher).

Current Assets

251.75 MUSD

YoY

24.00%

Last updated:

Current Assets of Personalis is 2026 251.75 M USD. Current Assets of Personalis was 2025 203.02 M USD. It decreases by 24.00% higher compared to the previous year.
Access this data via the Eulerpool API

Personalis Stock analysis

What does Personalis do? Personalis Inc is a diagnostic company specializing in the development of tests for personalized medicine. The company was founded in 2011 by Dr. Richard Chen and Dr. Erin Newburn and is headquartered in Menlo Park, California. They initially focused on developing genomic tools for cancer diagnosis and treatment but have expanded their offerings to include tests for rare genetic diseases, immunotherapies, and precision oncology drugs. They work closely with pharmaceutical and biotechnology companies as well as academics to develop innovative therapeutic approaches. Their business model is based on making genomics biology usable for personalized medicine and clinical research. They have a wide portfolio of genomic-based solutions for personalized medicine, including tests for tumor mutations, tumor-specific neoantigens, rare genetic diseases, and personalized immunotherapy. They also offer customized genomic solutions for pharmaceutical and biotechnology companies. Personalis Inc aims to establish personalized medicine quickly and effectively to provide the best possible outcome for patients. Personalis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Personalis stock

Current Assets of Personalis is 251.75 M USD in 2026.

Current Assets of Personalis changed from 203.02 M USD to 251.75 M USD, representing a 24.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Personalis since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Personalis historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Personalis

All Key Metrics — Personalis